Schechter Adam H, PRES, CEO, reported an open-market or private sale at LABCORP HOLDINGS INC. involving 6121.000000 shares for an estimated $1497319.02. Reported holdings after the transaction were 86445.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
Form 4 relationship flags and nearby filing context
President & CEO
Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
Stock withholding to satisfy tax withholding obligations.
Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
The option vests in three equal annual installments beginning on the date reflected in this column.
The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026.
This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested.
0 other filings
0 recent txs